Latest Clobetasol Propionate Stories
ALLEGAN, Mich., Aug. 19 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced its filing with the U.S.
ALLEGAN, Mich., July 14 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced its filing with the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clobetasol Propionate Emulsion Foam, 0.05% and notified Stiefel Research Australia Pty.
FORT WORTH, Texas, April 13 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new nozzle for ClobexÂ® (clobetasol propionate 0.05%) Spray, a super-potent topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older.
CINCINNATI, Dec. 22 /PRNewswire/ -- Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics.
ALLEGAN, Mich., Dec. 9 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has filed an Abbreviated New Drug Application for Clobetasol Propionate Topical Spray, 0.05%, a generic form of ClobexÂ® Spray.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.